The effect of hemodialysis (Kolff-type machine) on clindamycin blood levels in anuric patients was studied. At 1 hr after oral ingestion of drug, blood levels ranged from 1.23 to 5.17 Aug/ml and fell thereafter. Half-times for peripheral removal were 3.36 ,ug/ml i 0.22 when subjects were "off" dialysis and 3.14 ,ug/ml ±+i 0.09 during dialysis. Their difference was not statistically significant, indicating that hemodialysis does not affect the blood level of clindamycin. In all studies, significant levels of the antibiotic were present at 12 hr.
The emergence of maintenance hemodialysis from the experimental to the therapeutic phase has emphasized the necessity of making available sufficient information on the dialysis properties of new drugs as they are being introduced.
Clindamycin is a new antibiotic derived from lincomycin. Although the bacterial spectrum is similar for possible. The serum specimens were assayed undiluted. All of the specimens from a single subject were assayed on the same day and calculated against secondary standards. Zero is equal to or less than 0.4 ug/ml.
Artificial kidney. A Kolff-Travenol hemodialyzer was used (1, 9). This dialyzer utilizes a disposable unit consisting of two cellophane tubes in parallel arrangement, enveloped in fiberglass screens and wrapped around a central core. Dialysate fluid is pumped between the layers of the blood-filled tubing so that dialysis or exchange takes place. The flow of blood through the artificial kidney machine (Sarns pump used) per minute varied from 200 to 400 I Blood-urea-nitrogen, expressed as mg/100 ml. naln-time was calculated grapnmcally. i ne natiThe dialyzability of dindamycin was examined life for clindamycin "off" dialysis is 3.36 i 0.22 inTfoureof dl lthefivepatintsInone instance, and "on" dialysis is 3.14 i 0.09. The average in four of the five patients. In one half-life for clindamycin in subjects with normal patient P.L. discontinued the drug because of renal function is 2.55 hr (personal communicaabdominal pain, diarrhea, nausea, and vomiting tion).
after receiving only two doses. We were not conOf the five patients who participated in the vinced that these symptoms were due to the drug. study, four were anuric and one was severely Patient G.H. actually had an increased blood oliguric. The one oliguric patient's urinary outlevel while on dialysis. This may have been put during hemodialysis was so small that it owing to gastric retention and continued ab-would have been fruitless to carry out a urinary sorption of the antibiotic secondary to known recovery of clindamycin. Individual half-times duodenal disease.
for "on" and "off" dialysis studies are listed in Table 2 shows serum levels of clindamycin for Table 4 . The difference in half-time during patients on hemodialysis; Table 3 
